Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection with and without cirrhosis

被引:1
作者
Chayama, K. [1 ]
Suzuki, F. [2 ]
Sato, K. [3 ]
Atarashi, T. [4 ]
Watanabe, T. [5 ]
Toyoda, H. [6 ]
Atsukawa, M. [7 ]
Naganuma, A. [8 ]
Notsumata, K. [9 ]
Osaki, Y. [10 ]
Nakamuta, M. [11 ]
Takaguchi, K. [12 ]
Saito, S. [13 ]
Kato, K. [14 ]
Pugatch, D. L. [14 ]
Burroughs, M. [14 ]
Redman, R. [14 ]
Alves, K. [14 ]
Pilot-Matias, T. [14 ]
Fu, B. [14 ]
Kumada, H. [2 ]
机构
[1] Hiroshima Univ Hosp, Hiroshima, Japan
[2] Toranomon Gen Hosp, Kawasaki, Kanagawa, Japan
[3] Gunma Univ Hosp, Maebashi, Gunma, Japan
[4] JA Hokkaido PWFAC Obihiro Kosei Gen Hosp, Obihiro, Hokkaido, Japan
[5] St Marianna Univ Sch, Kawasaki, Kanagawa, Japan
[6] Ogaki Municipal Hosp, Ogaki, Japan
[7] Chiba Hokusoh Hosp, Nippon Med Sch, Inzai, Japan
[8] NHO Takasaki Gen Med Ctr, Fukuoka, Japan
[9] Fukuiken Saiseikai Hosp, Fukui, Japan
[10] Osaka Red Cross Hosp, Osaka, Japan
[11] NHO Kyushu Med Ctr, Fukuoka, Japan
[12] Kagawa Prefectural Cent Hosp, Takamatsu, Kagawa, Japan
[13] Yokohama City Univ Med, Yokohama, Kanagawa, Japan
[14] AbbVie, N Chicago, IL USA
关键词
D O I
10.1016/S0168-8278(17)31457-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-263
引用
收藏
页码:S528 / S528
页数:1
相关论文
empty
未找到相关数据